Actually you are confused. DOC didn't license anything to Merck or Astra or Bmy or any BP except AMGN (who terminated the deal). DOC's company paid for the trials, got no cash payments up front from MERck, Astra or BMY. Pure cash burn with no guarantee of any revenues. Just like this deal.